Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEAM vs GSK✓SelectedUSD · GSKTEAM vs GSK performance historyLatest closeAs of+1.23%11/20
Stock and ETF performance explorer

TEAM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-6.5%
GSK return
+6.1%
Excess return
-12.7%
Maximum drawdown
-65.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.2%-0.1%+1.4%+1.2%
7D-10.2%-5.3%-4.9%-11.4%
30D-40.3%-3.7%-36.6%-40.7%
3M-23.0%-7.3%-15.8%-24.7%
6M+56.2%-4.2%+60.4%+56.1%
YTD-17.0%+0.9%-17.8%-25.1%
1Y-6.5%+7.3%-13.8%-15.8%
All-6.5%+6.1%-12.7%-15.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling